SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-21-008271
Filing Date
2021-04-08
Accepted
2021-04-08 08:00:30
Documents
13
Period of Report
2021-04-08
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 36300
2 ex1-1.htm EX-1.1 201246
  Complete submission text file 0001493152-21-008271.txt   454853

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE hrow-20210408.xsd EX-101.SCH 3190
4 XBRL LABEL FILE hrow-20210408_lab.xml EX-101.LAB 34592
5 XBRL PRESENTATION FILE hrow-20210408_pre.xml EX-101.PRE 22713
6 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3616
Mailing Address 102 WOODMONT BLVD SUITE 610 NASHVILLE TN 37215
Business Address 102 WOODMONT BLVD SUITE 610 NASHVILLE TN 37215 615.733.4731
HARROW HEALTH, INC. (Filer) CIK: 0001360214 (see all company filings)

IRS No.: 450567010 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35814 | Film No.: 21813807
SIC: 2834 Pharmaceutical Preparations